skip banner - Return to original view
site viewing options
 
Parents|Medical Information|Professionals|In your area|Campaigns

Fabry disease

Background

Anderson-Fabry: Angiokeratoma Corporis Diffusum: Haemorrhagic Nodular Glycolipid Lipidosis

Fabry disease is a rare inherited metabolic disorder. It results from reduced activity of the enzyme alpha-galactosidase (α-Gal A) and progressive accumulation of a fatty substance, globotriaosylceramide (GL-3 or GB-3), in cells throughout the body.

What are the symptoms? View What are the symptoms?

Medical text written November 1991 by Contact a Family. Approved November 1991 by Professor M Patton, Professor of Medical Genetics, St Georges Hospital Medical School, London, UK and Dr J E Wraith, Consultant Paediatrician, Royal Manchester Children's Hospital, Manchester, UK. Last updated January 2008 by Dr Derralyn Hughes, Lecturer in Haematology, Royal Free and University College Medical School, London, UK.

 

Tell us what you think of this information...

Print whole article Print whole article

 

This Web Site © Copyright, Contact a Family 2009
Contact a Family, 209-211 City Road, London EC1V 1JN
Tel: (020) 7608 8700

Registered Charity No. 284912. Charity registered in Scotland No. SC039169
Company limited by guarantee, registered in England and Wales No. 1633333.
HM Revenue & Customs charity tax reference No. XN54769. VAT Reg. No. GB 749 3846 82